Maze Therapeutics Inc (MAZE)

Stock-Based Compensation

$9.19M

Quarterly · Period ending: · USD

MAZE logo

MAZE Stock-Based Compensation

Latest reported$9.19M
MAZE Quarterly Stock-Based Comp ($2.11M → $9.19M)
High-resolution chart · PNG

MAZE stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Maze Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
9,187,000
7,109,000
6,073,000
3,864,000
3,237,000
3,226,000
2,851,000
2,343,000
2,142,000
2,310,000
2,557,000
2,113,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.